Literature DB >> 31673561

Early allograft dysfunction after liver transplantation with donation after cardiac death donors.

Junbin Zhou1,2, Qiang Wei1,2, Shusen Zheng1,2, Xiao Xu1,2.   

Abstract

Entities:  

Year:  2019        PMID： 31673561      PMCID： PMC6791983          DOI： 10.21037/hbsn.2019.07.07

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  12 in total

1.  Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors.

Authors:  Kim M Olthoff; Laura Kulik; Benjamin Samstein; Mary Kaminski; Michael Abecassis; Jean Emond; Abraham Shaked; Jason D Christie
Journal:  Liver Transpl       Date:  2010-08       Impact factor: 5.799

2.  Genomic profiles and predictors of early allograft dysfunction after human liver transplantation.

Authors:  S M Kurian; S M G Fouraschen; P Langfelder; S Horvath; A Shaked; D R Salomon; K M Olthoff
Journal:  Am J Transplant       Date:  2015-03-31       Impact factor: 8.086

Review 3.  Steatosis in Liver Transplantation: Current Limitations and Future Strategies.

Authors:  Ivan Linares; Matyas Hamar; Nazia Selzner; Markus Selzner
Journal:  Transplantation       Date:  2019-01       Impact factor: 4.939

4.  Grade of donor liver microvesicular steatosis does not affect the postoperative outcome after liver transplantation.

Authors:  Anne Andert; Tom Florian Ulmer; Wenzel Schöning; Daniela Kroy; Marc Hein; Patrick Hamid Alizai; Christoph Heidenhain; Ulf Neumann; Maximilian Schmeding
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2017-12-15

5.  Effects of therapeutic plasma exchange on early allograft dysfunction after liver transplantation.

Authors:  Wonho Choe; Seog-Woon Kwon; Sung-Soo Kim; Shin Hwang; Gi-Won Song; Sung-Gyu Lee
Journal:  J Clin Apher       Date:  2016-06-16       Impact factor: 2.821

6.  Evaluation of Early Allograft Function Using the Liver Graft Assessment Following Transplantation Risk Score Model.

Authors:  Vatche G Agopian; Michael P Harlander-Locke; Daniela Markovic; Wethit Dumronggittigule; Victor Xia; Fady M Kaldas; Ali Zarrinpar; Hasan Yersiz; Douglas G Farmer; Jonathan R Hiatt; Ronald W Busuttil
Journal:  JAMA Surg       Date:  2018-05-01       Impact factor: 14.766

7.  Successful donation after cardiac death liver transplants with prolonged warm ischemia time using normothermic regional perfusion.

Authors:  Riccardo De Carlis; Stefano Di Sandro; Andrea Lauterio; Fabio Ferla; Antonio Dell'Acqua; Marinella Zanierato; Luciano De Carlis
Journal:  Liver Transpl       Date:  2016-12-30       Impact factor: 5.799

8.  Impact of real-time metabolomics in liver transplantation: Graft evaluation and donor-recipient matching.

Authors:  Francois Faitot; Camille Besch; Stephanie Battini; Elisa Ruhland; Mihaela Onea; Pietro Addeo; Marie-Lorraine Woehl-Jaeglé; Bernard Ellero; Philippe Bachellier; Izzie-Jacques Namer
Journal:  J Hepatol       Date:  2017-12-02       Impact factor: 25.083

9.  Risk factors for allograft failure in liver transplant recipients.

Authors:  Anna Huesing-Kabar; Christina Zu Dohna; Hauke Heinzow; Vito Rosario Cicinnati; Susanne Beckebaum; Martina Schmidt; Hans Ulrich Gerth; Michele Pohlen; Christian Wilms; Daniel Palmes; Hartmut Hans-Jürgen Schmidt; Iyad Kabar
Journal:  Z Gastroenterol       Date:  2018-01-16       Impact factor: 2.000

10.  Donor liver apoptosis is associated with early allograft dysfunction and decreased short-term graft survival after liver transplantation.

Authors:  Zebin Zhu; Yunhua Tang; Shanzhou Huang; Qiang Zhao; Paul M Schroder; Zhiheng Zhang; Yixi Zhang; Chengjun Sun; Linhe Wang; Weiqiang Ju; Dongping Wang; Zhiyong Guo; Xiaoshun He
Journal:  Clin Transplant       Date:  2018-11-22       Impact factor: 2.863
View more
  1 in total

Review 1.  Expanding Indications for Liver Transplant: Tumor and Patient Factors.

Authors:  Kevin Ka-Wan Chu; Kelly Hiu-Ching Wong; Kenneth Siu-Ho Chok
Journal:  Gut Liver       Date:  2021-01-15       Impact factor: 4.519
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.